CD-related project received award for the best coordination
CyclonHit project was awarded for the best coordination as it went beyond the initially planned objectives, it highly involved women
Biodegradable antibacterial multilayer on polylactic acid-based food packaging
Polylactic acid (PLLA) was internally blended with zinc oxide nanoparticles and chitosan and carboxyethyl BCD (CEBCD) layers were deposited by
Sage Therapeutics Announces FDA Advisory Committee Votes 17-1 in Support of Benefit-Risk Profile of ZULRESSO™ (brexanolone) Injection for Treatment of Postpartum Depression
If approved, ZULRESSO would be the first medicine specifically indicated for the treatment of postpartum depression (PPD) Sage Therapeutics (NASDAQ:
Melinta Therapeutics Announces Positive Top-Line Results in Phase III Trial of Baxdela® (delafloxacin) for Treatment of CABP
Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, announced positive
HPBCD treatment for Niemann-Pick C: Mallinckrodt communicated results of clinical trial
Mallinckrodt Pharmaceuticals recently revealed findings of their completed registration trial for VTS-270 (Hydroxypropyl Betadex- HPBCD), a development product to treat
New Clinical Trial for Efficacy and Safety of Sugammadex in 0-2 Years Old Children
Federal Research Institute of Pediatric Hematology, Oncology and Immunology is about to launch a clinical study at Dmitry Rogachev National
Minimizing tissue reactions with cyclodextrins at infusion site of insulin therapy
A recently published patent application of Cell and Molecular Tissue Engineering LLC (WO2017180708) discloses a method of lowering the concentrations of
Strategies against antifungal resistance
A recent paper in Drug Design, Development and Therapy gives an overview on the new strategies to combat antifungal drug
Special Issue of the journal Materials “Cyclodextrin-Based Nanomaterials: Synthesis, Properties, and Applications”
Cyclodextrins (CDs) have become a very common building-block for the design of new smart materials of different nature. This is
HPBCD treatment of Alzheimer’s disease
CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with
Biodegradable nanofiber membranes for waste water decontamination
Novel biodegradable nanofilter membrane (BCD-PDA@PLA) was developed by electrospinning poly(L-lactic acid) (PLA) nanofibers as the scaffold, which were then surface